New PBS listings from 1 July 2022

1 July 2022 - Vitrakvi (larotrectinib) will list for the first time for the treatment of adult and paediatric patients with ...

Read more →

PBS listing for ‘Australian success story’ blood cancer drug

1 July 2022 - A pill that removes the need for chemotherapy for some cancer sufferers has been put on ...

Read more →

Schedule of Pharmaceutical Benefits - 1 July 2022

1 July 2022 - The July 2022 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...

Read more →

Schedule of Pharmaceutical Benefits - 1 June 2022

1 June 2022 - The June 2022 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...

Read more →

New Zealand Pharmaceutical Schedule - 1 June 2022

1 June 2022 - The June 2022 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...

Read more →

Janssen’s psoriatic arthritis drug Tremfya gets insurance coverage

26 May 2022 - Janssen Korea said that the Ministry of Health and Welfare would begin to reimburse Tremfya, its ...

Read more →

BMS’ Sprycel reimbursement criteria to be broadened for paediatric Philadelphia chromosome positive ALL

19 May 2022 - The state health insurance review agency said it would broaden the reimbursement criteria for Sprycel (dasatinib), ...

Read more →

Spravato approved for reimbursement in Ireland for adults with treatment-resistant major depressive disorder

16 May 2022 - Janssen has announced that Spravato (esketamine) nasal spray has been granted reimbursement in Ireland for the ...

Read more →

Fertility drug Rekovelle gets reimbursable in combo with hMG

10 May 2022 - Ferring’s Rekovelle (follitropin delta), a treatment to promote egg production in ovaries, became reimbursable when used ...

Read more →

First million dollar medicine listed on the PBS

4 May 2022 - Zolgensma has the great honour of being the first medicine listed on the PBS with a ...

Read more →

Boehringer Ingelheim Canada announces reimbursement for Ofev (nintedanib) in seven public drug plans for the treatment of progressive fibrosing interstitial lung diseases

3 May 2022 - Boehringer Ingelheim is pleased to announce that Ofev (nintedanib), is now available for public reimbursement in Quebec, ...

Read more →

Prices of Tecentriq, Avastin go down due to broader insurance benefits

2 May 2022 - The Government granted health insurance benefits to the combination therapy of Tecentriq and Avastin to treat ...

Read more →

COVID-19 oral treatment listed on PBS from 1 May 2022

1 May 2022 - This prescription only oral treatment has been found to be effective in treating mild to moderate ...

Read more →

Schedule of Pharmaceutical Benefits - 1 May 2022

1 May 2022 - The May 2022 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...

Read more →

New Pharmaceutical Benefits Scheme listings to save patients millions

1 May 2022 - Health Minister Greg Hunt has announced a series of new Pharmaceutical Benefits Scheme listings which will save ...

Read more →